NASDAQ:DOXAmdocs Stock Price, Forecast & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, DOX shares have decreased by 2.3% and is now trading at $60.02. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Amdocs.

Amdocs is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) announced its quarterly earnings results on Thursday, May, 7th. The technology company reported $1.08 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.06 by $0.02. The technology company had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.04 billion. Amdocs had a net margin of 11.98% and a return on equity of 16.03%. The company's quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.06 earnings per share. View Amdocs' earnings history.

Amdocs announced a quarterly dividend on Thursday, May 7th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.327 per share on Friday, July 24th. This represents a $1.31 annualized dividend and a yield of 2.18%. The ex-dividend date of this dividend is Monday, June 29th. View Amdocs' dividend history.

Amdocs issued an update on its third quarter earnings guidance on Thursday, May, 7th. The company provided EPS guidance of $1.00 to $1.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.16. The company issued revenue guidance of $990 million to $1.040 billion, compared to the consensus revenue estimate of $1.05 billion.

5 brokers have issued twelve-month price targets for Amdocs' shares. Their forecasts range from $72.00 to $85.00. On average, they expect Amdocs' share price to reach $76.40 in the next year. This suggests a possible upside of 27.3% from the stock's current price. View analysts' price targets for Amdocs.

Media coverage about DOX stock has been trending negative this week, according to InfoTrie. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Amdocs earned a news impact score of -2.4 on InfoTrie's scale. They also assigned media headlines about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Amdocs.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Leidos (LDOS), Booz Allen Hamilton (BAH), Gartner (IT), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and Servicesource International (SREV). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), Comcast (CMCSA), AT&T (T), Walt Disney (DIS), Gilead Sciences (GILD), Home Depot (HD), Intel (INTC), Pfizer (PFE), Verizon Communications (VZ) and Cisco Systems (CSCO).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Nelson Van Denburg & Campbell Wealth Management Group LLC (0.01%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Nelson Van Denburg & Campbell Wealth Management Group LLC.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $60.02.

Amdocs has a market capitalization of $8.09 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.

The official website for Amdocs is www.amdocs.com.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]